Pds Planning, Inc Amgen Inc Transaction History

Pds Planning, Inc

$1.1 Billion
Q3 2024

A detailed history of Pds Planning, Inc transactions in Amgen Inc stock. As of the latest transaction made, Pds Planning, Inc holds 2,349 shares of AMGN stock, worth $618,679. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,349

Previous 2,273 3.34%

Holding current value

$618,679

Previous $710,000 6.48%

% of portfolio

0.07%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $23,512 - $25,640	76 Added 3.34%	2,349 $756,000
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $33,632 - $40,871	128 Added 5.97%	2,273 $710,000
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $6,990 - $8,438	-26 Reduced 1.2%	2,145 $609,000
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $14,574 - $16,442	57 Added 2.7%	2,171 $625,000
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $32,797 - $40,719	150 Added 7.64%	2,114 $568,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $62,781 - $74,237	293 Added 17.53%	1,964 $436,000
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $125,313 - $152,736	555 Added 49.73%	1,671 $403,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $31,377 - $39,868	-137 Reduced 10.93%	1,116 $0
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $2,917 - $3,290	-13 Reduced 1.03%	1,253 $282,000
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $58,831 - $65,468	255 Added 25.22%	1,266 $308,000
Q1 2022 Apr 18, 2022	BUY	$219.27 - $242.57 $32,232 - $35,657	147 Added 17.01%	1,011 $244,000
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $171,832 - $196,646	864 New	864 $194,000
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $155,593 - $182,297	-733 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $171,214 - $189,949	733 New	733 $179,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account